Importantly, treatment of ALK5 inhibitor profoundly reduced the increased p‐ERK, p‐MEK, and c‐Myc expression caused by HOOK1 knockdown in RCC cells (Figure 5H). This evidence concerns the gene TGFBR1 and renal cell carcinoma.